Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in ...
Broadens vision to be supplier of choice to utilities and railroadsTargets annual sales of ~$4 billion by 2028, supported by current asset baseAims to maintain elevated EBITDA margin(1) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback